Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
384,731,503
-
Total 13F shares
-
26,899,693
-
Share change
-
-1,021,262
-
Total reported value
-
$195,651,510
-
Put/Call ratio
-
178%
-
Price per share
-
$7.28
-
Number of holders
-
80
-
Value change
-
-$9,634,235
-
Number of buys
-
31
-
Number of sells
-
48
Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q4 2016
As of 31 Dec 2016,
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,899,693 shares.
The largest 10 holders included
LEVIN CAPITAL STRATEGIES, L.P., PRIMECAP MANAGEMENT CO/CA/, Russell Investments Group, Ltd., WASATCH ADVISORS INC, ORBIMED ADVISORS LLC, Neuberger Berman Group LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, ADAGE CAPITAL PARTNERS GP, L.L.C., and BlackRock Institutional Trust Company, N.A..
This page lists
80
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.